Richard Pazdur is an Oncology physician affiliated with United States Food and Drug Administration. OpenAlex indexes 1,063 publications with 62,789 citations (h-index 134). By OpenAlex citation count, this profile ranks in the top 5% of Hematology / Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
10202 Addison Ct
Bethesda, MD 208171681
Telephone
301-897-5828Registry record last updated 25 Jul 2009.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden–High Solid Tumors
Clinical Cancer Research
2021 - FDA Approval Summary: Sotorasib for <i>KRAS G12C</i> -Mutated Metastatic NSCLC
Clinical Cancer Research
2021 - FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors
Clinical Cancer Research
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Marc Theoret, MD
United States Food and Drug Administration
Wellington Sun, MD
United States Food and Drug Administration
John Laschinger, MD
United States Food and Drug Administration
Cara Rabik, MD, PhD
United States Food and Drug Administration
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”